“…In addition to its clinical utility, oxaliplatin is also used in pharmacological laboratories to induce a rodent model of CIPN‐related neuropathic pain that could be utilized in the search for novel therapies for CIPN prevention (Ohsawa et al., ) and treatment (Andoh, Kitamura, & Kuraishi, ; Deuis et al., ; Jiang et al., ; Kim et al., ; King et al., ; Pańczyk et al., ; K. Sałat et al., , ; Sałat & Sałat, ; Yoon, Lee, Roh, & Oh, ). To assess the effect of oxaliplatin on tactile allodynia, researchers worldwide take advantage of using von Frey filaments as an easy‐to‐use method.…”